Understand the source comparison
Quickcomparison
Dose Range VIP (Vasoactive Intestinal Peptide) 67 mcg/day–300 mcg/day mcg PACAP-38 5 pmol/kg/min–20 pmol/kg/min mg Frequency Once daily Administration Intravenous infusion Cycle Length Ongoing/indefinite Onset Speed Moderate (1-2 weeks) Evidence Level Moderate
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Dose Range
- VIP (Vasoactive Intestinal Peptide)
- 67 mcg/day–300 mcg/day mcg
- PACAP-38
- 5 pmol/kg/min–20 pmol/kg/min mg
- Frequency
- Once daily
- Administration
- Intravenous infusion
- Cycle Length
- Ongoing/indefinite
- Onset Speed
- Moderate (1-2 weeks)
- Evidence Level
- Moderate human trials (Phase 1-2)
- Strong human trials (Phase 3 or FDA approved)
- Efficacy